Characteristic | Active recurrence (A-RP) | Not symptomatic, Corticosteroid-dependent (CSD-RP) |
---|---|---|
N = 16 | N = 9 | |
Age (years) (Mean ± SD [range]) | 39.8 ± 10.52 (26–58) | 48.2 ± 8.56 (36–62) |
Gender (% female [n]) | 75.0% (n = 12) | 33.3% (n = 3) |
Race (% white [n]) | 81.3% (n = 13) | 100% (n = 9) |
BMI (kg/m2) (Mean ± SD [range]) | 31.99 ± 7.51 (23.4–52.7) | 28.97 ± 4.68 (22.5–34.3) |
Duration of disease (years) (Mean ± SD [range]) | 2.6 ± 2.13 (0.2–7.9) | 1.4 ± 0.97 (0.6–3.4) |
Number of prior recurrences (median, [range]) | 2 (1–8) | 3 (2–5) |
Baseline NRS Pain Rating 0–10 (Mean ± SD [range]) | 4.6 ± 1.82 (2–8) | 1.4 ± 1.51 (0–5) |
Baseline CRP values (mg/dL) (Mean ± SD [range]) | 3.8 ± 5.30 (0.09–19.84) | 0.19 ± 0.11 (0.05–0.36) |
Concomitant medications at baseline | ||
Aspirin (n [%]) | 0 (0%) | 2 (22.2%) |
NSAID (n [%]) | 7 (43.8%) | 5 (55.6%) |
Colchicine (n [%]) | 12 (75.0%) | 8 (88.9%) |
CS (n [%]) | 6 (37.5%)a | 9 (100.0%)b |